Vol 33,2024 No.7 | Articles | Chinese Journal of Pharmacoepidemiology

Home Articles Vol 33,2024 No.7

 Contents

Vol 33,2024 No.7

Date of publication: July 15, 2024

 Get cover  Get contents

Pharmacoeconomic evaluation of fluticasone furoate/umeclidinium/ vilanterol powder for inhalation for the treatment of chronic obstructive pulmonary disease

DING Xueru LIU Huimin HE Xiaodong LI Hua LI Zhihao

2024,33(7):721-730

Fluticasone furoate/umeclidinium/vilanterol Chronic obstructive pulmonary disease Markov model Cost-utility analysis Pharmacoeconomic
Details Download Mobile
Data mining based on the dosage pattern of Chinese herbal compound patents for the treatment of influenza

LI Zhen HUANG Xiajin YIN Wenjing WANG Haifeng

2024,33(7):731-742

Influenza Chinese herbal compound Patent Association rules Factor analysis Cluster analysis Medication pattern
Details Download Mobile
Investigation and influential factors analysis of knowledge-attitude-practice concerning medication risks among university students in Karamay

SHI Yang CHEN Zhendong ZHANG Shengzhao TAN Xue FAN Dengfeng CHEN Xiaoli

2024,33(7):743-752

Medication risk Knowledge-attitude-practice Karamay University students Influential factors Rational drug use
Details Download Mobile
Mining and analysis for ocular adverse event signals induced by ALK inhibitors based on FAERS database

LUO Banglong ZHOU Yanping SU Rui

2024,33(7):753-759

ALK inhibitors FAERS database Ocular adverse events Signal mining Pharmacovigilance
Details Download Mobile
Study on the disease burden and prediction of substance use disorder in China based on age-period-cohort model

BI Hui MA Danhua XU Guili HUA Yunpeng XING Liang

2024,33(7):760-769

Drug abuse Substance use disorder Disease burden Trend analysis Age-period-cohort model
Details Download Mobile
A real-world study of the efficacy and safety of linezolid versus vancomycin in the treatment of Enterococcal bloodstream infections

TANG Bingying YI Maoli GAO Ting HUO Xuechen

2024,33(7):770-777

Bloodstream infection Enterococci Linezolid Vancomycin Efficacy Safety Propensity score matched
Details Download Mobile
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

QIN Fang WU Kunrong LIU Chengyu LIU Daihua

2024,33(7):778-789

Ertugliflozin Type 2 diabetes mellitus Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details Download Mobile
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

2024,33(7):790-800

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details Download Mobile
Bibliometric analysis of the application of machine learning in pharmacovigilance

LI Limin WU Wenyu WEI Fenfang Tang Biyu WU Jianru

2024,33(7):801-811

Machine learning Pharmacovigilance Bibliometrics
Details Download Mobile